Matching slides 11,828
Current window 5,761-5,790
Pages 395
Rows per page 30
Slide function: Show Tractionclear collectionreset all

Slide function

5,761-5,790 of 11,828

filter-aware
27
The slide uses a grid layout to present growth metrics across different segments.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
29
Includes brand performance metrics and financial KPIs for Q4 2022.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
30
Includes footnotes regarding non-GAAP adjustments.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · FinancialsLoop · Quick Win Big Bet1 hit
35
The chart highlights a 54% five-year annualized TSR for Crocs, significantly outperforming the benchmarks.Crocs | Investor Presentation Deck | 47 slides · Crocs
Pitch deck Investor relations Beat · Financials1 hit
09
Includes specific financial terms of the collaboration and regulatory milestones.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations 1 hit
19
The slide highlights a key partnership milestone and the associated financial structure (upfront payment and potential milestones).Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
27
Includes details on milestone payments, royalties, and strategic support from Bayer.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
28
Includes a testimonial quote from a Bayer executive.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
34
The slide outlines the methodology and goals of a clinical trial, specifically mentioning the RESPOND study.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
35
The slide uses clinical trial data to justify the pivot to a topical delivery mechanism.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
41
The slide highlights statistically significant improvements (p<0.01) across multiple clinical endpoints.Dare Bioscience | Investor Presentation Deck | 54 slides · Daré Bioscience
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
07
The slide uses a consistent three-column layout to present growth data for three distinct KPIs.Honest | Investor Presentation Deck | 19 slides · Honest
Pitch deck Investor relations Beat · Rising SuccessLoop · Aha Moment1 hit
08
The slide uses a three-column layout to illustrate the synergy between content creation, social media reach, and retail distribution.Honest | Investor Presentation Deck | 19 slides · Honest
Pitch deck Investor relations Beat · Rising SuccessLoop · Aha Moment1 hit
11
Includes a pie chart showing 63% sales contribution and a bar chart comparing 2Y CAGR of the baby category vs total MULO.Honest | Investor Presentation Deck | 19 slides · Honest
Pitch deck Investor relations Beat · Rising SuccessLoop · Golden Circle1 hit
13
Category growth = conventional brands. Source: Third Party Data, last 12 weeks ending 12/31/2021 compared to last year.Honest | Investor Presentation Deck | 19 slides · Honest
Pitch deck Investor relations Beat · Rising SuccessLoop · Golden Circle1 hit
14
Includes a comparison chart showing 25% CAGR for the Beauty Category vs -1% for the Total Mass Market.Honest | Investor Presentation Deck | 19 slides · Honest
Pitch deck Investor relations Beat · The BreakthroughLoop · Golden Circle1 hit
17
The slide uses a table to demonstrate market traction and growth opportunities for specific service lines.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Traction1 hit
23
Includes two combo charts showing quarterly financial performance and CapEx trends.ModivCare | Investor Presentation Deck | 36 slides · ModivCare
Pitch deck Investor relations Beat · Traction1 hit
28
The slide highlights high-multiple returns on specific hedging instruments during market volatility.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations 1 hit
29
The chart uses a callout box to highlight peak losses in March 2009.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations 1 hit
30
The chart uses a callout box to explicitly compare peak losses during the March 2020 market downturn.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations 1 hit
31
The slide highlights performance during a specific volatile year and references historical performance during bear markets.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations 1 hit
39
The chart uses a timeline-based annotation style to correlate market events with share price fluctuations.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
41
The chart includes a baseline reference of $86* and specific callouts for CEO hiring, analyst days, and strategic divestitures.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
42
Slide from a Pershing Square presentation.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
45
The chart highlights specific acquisition and leadership transition events as inflection points on the share price trajectory.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
47
The chart includes a dashed line indicating an average cost basis of $73* and callout boxes explaining specific market events affecting the share price.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
49
The slide uses a timeline-annotated line chart to contextualize stock performance with specific management and investment milestones.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations Beat · Market Size1 hit
51
The slide uses a timeline-annotated line chart to correlate share price volatility with specific litigation and policy milestones.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations 1 hit
53
The chart highlights specific regulatory and operational events impacting the share price.Pershing Square | Investor Presentation Deck | 62 slides · Pershing Square Holdings
Pitch deck Investor relations 1 hit